MyStroke in Chronic Stroke

Study Overview
=================
Brief Summary
-----------------
This is a single-center randomized control trial assessing the impact of a personalized video-based educational platform on patients satisfaction and stroke knowledge in the context of chronic stroke.

Official Title
-----------------
Personalized Video-based Education for Chronic Stroke Survivors: A Randomized Clinical Trial

Conditions
-----------------
Stroke

Intervention / Treatment
-----------------
* Behavioral: MyStroke


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: History of ischemic stroke between 1 and 10 years prior to enrollment Receiving outpatient stroke care at the Hospital of the University of Pennsylvania At least 18 years old Access to a smart phone, tablet, or computer Willingness to complete 2 follow-up surveys (7 days and 90 day post-enrollment) Exclusion Criteria: Unwilling or unable to access the customized app with a smartphone, tablet, or computer Complete dependence on caregiver for all activities of daily living Stroke occurred less than 1 year or greater than 10 years prior to screening/enrollment Patient has severe aphasia (score of greater than or equal to 2 on National Institutes of Health Stroke Scale item 9)

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| No Intervention: Standard Education<br>Standard stroke patient education as per the medical providers | |
| Experimental: MyStroke<br>Access to a personalized video-based stroke educational platform | Behavioral: MyStroke<br>* Personalized video-based stroke education platform<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Patient satisfaction with stroke education (90 days) | 5-point Likert-scale (Q: I am satisfied with the quality of my stroke education; Answers range from strongly disagree to strongly agree) | 90 days | 
| Stroke etiology recognition (90 days) | The proportion of patients who correctly identify their stroke etiology | 90 days | 
| Stroke risk factor recognition (90 days) | The proportion of patients who correctly identify at least one of their vascular risk factors | 90 days | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Stroke prevention medication recognition (7 days) | The proportion of patients who correctly identify their antithrombotic medications | 7 days | 
| Stroke prevention medication recognition (90 days) | The proportion of patients who correctly identify their antithrombotic medications | 90 days | 
| Patient satisfaction with stroke education (7 days) | 5-point Likert-scale (Q: I am satisfied with the quality of my stroke education; Answers range from strongly disagree to strongly agree) | 7 days | 
| Stroke etiology recognition (7 days) | The proportion of patients who correctly identify their stroke etiology | 7 days | 
| Stroke risk factor recognition (7 days) | The proportion of patients who correctly identify at least one of their vascular risk factors | 7 days | 
| Stroke patient education retention (SPER) survey (7 days) | total score from the 5-question SPER (scale 0-10; higher score reflects better knowledge) | 7 days | 
| Stroke patient education retention (SPER) survey (90 days) | total score from the 5-question SPER (scale 0-10; higher score reflects better knowledge) | 90 days | 
| EuroQOL - visual analog scale (7 days) | patient-reported quality of life score (scale 0-100; higher score reflects better self-reported quality of life) | 7 days | 
| EuroQOL - visual analog scale (90 days) | patient-reported quality of life score (scale 0-100; higher score reflects better self-reported quality of life) | 90 days | 
| modified Rankin Scale | Ordinal functional disability scale (score 0 - 6) | 90 days | 
| Medication adherence (7 days) | total score of the Adherence Estimator (3 question survey; total score 0-36; higher score reflects higher risk of non-adherence) | 7 days | 
| Medication adherence (90 days) | total score of the Adherence Estimator (3 question survey; total score 0-36; higher score reflects higher risk of non-adherence) | 90 days |